<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000630957"><TermName>SNDX-275</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor.  Also called entinostat and HDAC inhibitor SNDX-275.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>SNDX-275</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de varios tipos de cáncer. Bloquea enzimas que las células necesitan para multiplicarse y puede destruir células cancerosas. Es un tipo de inhibidor de la histona deacetilasa (HDAC).  También se llama entinostat y inhibidor de HDAC SNDX-275.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-19</DateFirstPublished></GlossaryTerm>
